6505-01-413-1331 Varicella virus vaccine live
One item DLA buys: its open requests for quotation, approved sources and past DLA awards.
Overview
National Stock Number record
- Open RFQs
- 2
- Next due November 16, 2026
- Last price paid
- …
- Standard price
- $2,257.49 per PG
- DLA's catalog price, not a price paid
- Approved sources
- 1
- One approved manufacturer listed
- Awards on record
- 91
- 2013 to 2026
- DLA demand
- –
Identification
- Item name
- Varicella virus vaccine live
- FSC / PSC
- 6505 · Drugs and biologicals
- NSG (group)
- 65 · Medical/dental/veterinary eqpt/supp
- NIIN assigned
- 05-MAY-95
- Unit
- PG
- NSN
- 6505-01-413-1331
- NIIN
- 01-413-1331
Name, end product, NIIN date and unit: DLA's Federal Logistics Information System (PUB LOG). Source: the request-for-quotation (RFQ) files DLA publishes on DIBBS each day. An RFQ that is also a SAM.gov notice links to that notice. Return-by dates are DIBBS's.
Approved suppliers
Manufacturers and part numbers DLA has qualified for this item, and the part numbers in its catalog record
| Supplier | CAGE | CAGE status | Part status (RNCC / RNVC) | Supplier part # | Listed in |
|---|---|---|---|---|---|
| MERCK SHARP & DOHME LLCWon before | 6B2S4 | A (Active) | 3 (Design control reference) / 2 (An item-identifying number) | NDC00006-4827-00 | DLA approved-source file |
| MERCK SHARP & DOHME LLCWon before | 6B2S4 | A (Active) | 5 (Secondary reference) / 1 (Not identify an item of production without the use of additional information) | VARIVAX | FLIS part list |
Source: DLA's approved-source file published with the RFQs and the part list of DLA's catalog record (FLIS). CAGE and part status are FLIS's codes with DLA's wording.
Pricing and awardees
Supply contracts
1 contract DLA ordered this item under
| Award ID | Awardee | Awarding office | Ceiling | Ordering ends | Type | Multiple award | Orders | Last order |
|---|---|---|---|---|---|---|---|---|
| SPE2DX15D9383 | DMS PHARMACEUTICAL GROUP INC | SPE2DX | $4,999,999 | December 31, 2025 | INDEFINITE DELIVERY / INDEFINITE QUANTITY | No | 1 | October 9, 2018 |
Source: DLA's procurement history files (the contract each order was placed under), the item's newest 2,000 award lines, joined to FPDS by the contract number. Multiple award, ordering period and ceiling are FPDS's; DLA's files do not give them.
Characteristics
Government-defined characteristics of this item (FLIS)
Hazardous and environmental
- Hazardous material (HMIC)
- P (No information in hmirs)
Product characteristics
| Code | Requirement | Description |
|---|---|---|
| CXCY | Part name assigned by controlling agency | VARICELLA VIRUS VACCINE LIVE 10 VIALS PG |
| FEAT | Special features | 10 SINGLE DOSE VIALS OF LYOPHILIZED VACCINE AND 10 VIALS OF DILUENT; 1350 PFU/0.5 ML VIAL, 10 VIALS PER PKG; PART A SHOULD BE STORED FROZEN AND PART B MAY BE STORED AT ROOM TEMP. OR REFRIGERATED. |
Additional identifiers
- II
- 0
- DEMIL
- A: No demilitarization required
- Precious metals (PMIC)
- A (Does not contain precious metal)
- Schedule B
- 3002200000
- PINC
- 0051796
- Criticality (CRIT CD)
- X
- On FedMall
- Yes
Source: DLA's PUB LOG files (FLIS Data Electronic Reading Room), updated monthly; code wording from DLA's code table (P_HELP).
Major organizational entity (MOE) rules
How each service or agency buys and manages this item
| Rule | MOE | AMC | AMSC | NIMSC | IMC | AAC | DSOR |
|---|---|---|---|---|---|---|---|
| A911 | Army (DA) | 1Suitable for competition (second or later time) | ZCommercial or off-the-shelf item | ||||
| FSGM | Air Force (DF) | 1Suitable for competition (second or later time) | ZCommercial or off-the-shelf item | ||||
| N9BL | Navy (DN) | 1Suitable for competition (second or later time) | ZCommercial or off-the-shelf item | ||||
| VP01 | Peru (VP) |
Source: DLA's PUB LOG files (FLIS Data Electronic Reading Room), updated monthly; code wording from DLA's code table (P_HELP). AMC and AMSC wording: DFARS PGI 217.7506. Hover a code for DLA's wording.
Government organizations
The services and agencies that manage or use this item
| Organization | Effective date | Unit of issue | Unit price | Qty per unit | Controlled inventory | Shelf life | Acquisition advice | Source of supply |
|---|---|---|---|---|---|---|---|---|
| Army (DA) | 01-OCT-2025 | PG | $1,616.00 | 1 (1) | U (Unclassified) | K (18 months) | L (Local purchase) | SMS (Defense logistics agency) |
| Air Force (DF) | 01-OCT-2025 | PG | $1,616.00 | 1 (1) | U (Unclassified) | K (18 months) | L (Local purchase) | SMS (Defense logistics agency) |
| Navy (DN) | 01-FEB-2026 | PG | $1,616.00 | 1 (1) | U (Unclassified) | K (18 months) | L (Local purchase) | SMS (Defense logistics agency) |
| DLA (DS) | 01-OCT-2026 | PG | $2,257.49 | 1 (1) | U (Unclassified) | K (18 months) | L (Local purchase) | SMS (Defense logistics agency) |
Source: DLA's PUB LOG files (FLIS Data Electronic Reading Room), updated monthly; code wording from DLA's code table (P_HELP). Unit prices are DLA's standard prices (its catalog price to its customers, with DLA's surcharge), not prices DLA paid.
Packaging
FLIS packaging data of this item
FLIS packaging
- Unit pack weight
- 1 lb
- Unit pack cube
- 0.007 cu ft
- Level A
- Z (Special requirement)
- Unit container
- ZZ (Special requirement)
Source: DLA's PUB LOG files (FLIS Data Electronic Reading Room), updated monthly; code wording from DLA's code table (P_HELP).
DIBBS RFQs
Recent DLA requests for quotation for this item on DIBBS, newest first: 2 open now
| Solicitation | NSN | Item name | Qty | Unit | Std. price | Last price | Est. value | Set-aside | Tech docs | Posted | Return by |
|---|---|---|---|---|---|---|---|---|---|---|---|
| SPE2DP27T0248DIBBS only | 6505-01-413-1331 | Varicella virus vaccine live | 1 | PG | $2,257.49 per PG | … | … | No set-aside | No | November 6, 2026 | November 17, 20264 days left |
| SPE2DP27T0243DIBBS only | 6505-01-413-1331 | Varicella virus vaccine live | 1 | PG | $2,257.49 per PG | … | … | No set-aside | No | November 4, 2026 | November 16, 20263 days left |
| SPE2DP26T3771DIBBS only | 6505-01-413-1331 | Varicella virus vaccine live | 1 | PG | $2,257.49 per PG | … | … | No set-aside | November 3, 2026First seen | June 22, 2026Closed | |
| SPE2DP26T3898DIBBS only | 6505-01-413-1331 | Varicella virus vaccine live | 1 | PG | $2,257.49 per PG | … | … | No set-aside | November 3, 2026First seen | July 6, 2026Closed | |
| SPE2DP26T5128DIBBS only | 6505-01-413-1331 | Varicella virus vaccine live | 2 | PG | $2,257.49 per PG | … | … | No set-aside | November 3, 2026First seen | September 25, 2026Closed |
→ These RFQs in the DIBBS list
“First seen”: an RFQ from DIBBS's file of all open RFQs, which gives no issue date. Source: the request-for-quotation (RFQ) files DLA publishes on DIBBS each day. An RFQ that is also a SAM.gov notice links to that notice. Return-by dates are DIBBS's.
DLA forecast
DLA's purchase forecast for the next 24 months, and its lead time
DLA's own figures
- Lead time
- administrative 15 days, production 113 days (128 in all)
Source: DLA's monthly files in its FOIA reading room: the 24-month demand forecast (what DLA expects to buy, not a commitment) and the ALT/PLT file (administrative lead time: requirement to award; production lead time: award to delivery).
DLA award history
91 award lines since 2013, 7 winning CAGEs
| Winner | Awards | Last award |
|---|---|---|
| 1UNB0DMS PHARMACEUTICAL GROUP INC | 39 | August 13, 2026 |
| 6B2S4MERCK SHARP & DOHME LLC | 37 | November 3, 2016 |
| 06990MERCK SHARP DOHME CORP. DIV US | 7 | November 14, 2013 |
| 5J522DIXON-SHANE LLC | 3 | December 28, 2016 |
| 0AG09SZY HOLDINGS, LLC | 3 | February 4, 2015 |
| 3W8H0MR UNLIMITED, LLC | 1 | August 8, 2017 |
| 1KA59ARS SALES & SERVICES LLC | 1 | March 16, 2017 |
| Year | Awards | Winning CAGEs |
|---|---|---|
| 2026 | 5 | 1 |
| 2025 | 3 | 1 |
| 2024 | 7 | 1 |
| 2021 | 11 | 1 |
| 2020 | 2 | 1 |
| 2019 | 9 | 1 |
| 2018 | 1 | 1 |
| 2017 | 3 | 3 |
| 2016 | 7 | 2 |
| 2015 | 11 | 2 |
| 2014 | 18 | 2 |
| 2013 | 14 | 2 |
Source: DLA's award history files (its FOIA reading room: every DLA award line since 2013, refreshed monthly), plus the past awards listed in this item's RFQ documents that those files lack. Counts are award lines, not dollars; surplus buys are left out.
DLA awards for this item
25 awards from the item's award history, in FPDS
| Rank | Vendor | Obligated | |
|---|---|---|---|
| 1 | MERCK SHARP & DOHME LLC | $424,916 | 26 |
| 2 | DMS PHARMACEUTICAL GROUP INC | $121,750 | 38 |
| 3 | SZY HOLDINGS, LLC | $63,652 | 3 |
| 4 | ARS SALES & SERVICES LLC | $36,418 | 1 |
| 5 | MR UNLIMITED, LLC | $12,068 | 1 |
| Contract | Awarded | Awardee | Obligated |
|---|---|---|---|
| SPE2DP26P1091From the item's award history | August 13, 2026 | DMS PHARMACEUTICAL GROUP INC | $1,246 |
| SPE2DP26P0590From the item's award history | March 17, 2026 | DMS PHARMACEUTICAL GROUP INC | $1,246 |
| SPE2DP26P0592From the item's award history | March 17, 2026 | DMS PHARMACEUTICAL GROUP INC | $1,246 |
| SPE2DP26P0593From the item's award history | March 17, 2026 | DMS PHARMACEUTICAL GROUP INC | $1,246 |
| SPE2DP26P0587From the item's award history | March 12, 2026 | DMS PHARMACEUTICAL GROUP INC | $1,246 |
| SPE2DP26P0178From the item's award history | December 4, 2025 | DMS PHARMACEUTICAL GROUP INC | $1,131 |
| SPE2DP25P0504From the item's award history | July 10, 2025 | DMS PHARMACEUTICAL GROUP INC | $1,130 |
| SPE2D025F0139From the item's award history | December 23, 2024 | DMS PHARMACEUTICAL GROUP INC. | $1,113 |
| SPE2D024F0631From the item's award history | September 16, 2024 | DMS PHARMACEUTICAL GROUP INC | $6,678 |
| SPE2D024F0578From the item's award history | September 4, 2024 | DMS PHARMACEUTICAL GROUP INC | $6,678 |
| SPE2D024F0549From the item's award history | August 22, 2024 | DMS PHARMACEUTICAL GROUP INC | $1,113 |
| SPE2D024F0535From the item's award history | August 16, 2024 | DMS PHARMACEUTICAL GROUP INC | $1,113 |
| SPE2D024F0368From the item's award history | July 11, 2024 | DMS PHARMACEUTICAL GROUP INC | $1,113 |
| SPE2D024F0274From the item's award history | May 30, 2024 | DMS PHARMACEUTICAL GROUP INC | $1,113 |
| SPE2DP22P0068From the item's award history | October 20, 2021 | DMS PHARMACEUTICAL GROUP INC | $929 |
| SPE2DP22P0080From the item's award history | October 20, 2021 | DMS PHARMACEUTICAL GROUP INC | $929 |
| SPE2DP22P0081From the item's award history | October 20, 2021 | DMS PHARMACEUTICAL GROUP INC | $929 |
| SPE2DP21P0904From the item's award history | August 26, 2021 | DMS PHARMACEUTICAL GROUP INC | $929 |
| SPE2DP21F5620From the item's award history | August 13, 2021 | DMS PHARMACEUTICAL GROUP INC | $929 |
| SPE2DP21F5621From the item's award history | August 13, 2021 | DMS PHARMACEUTICAL GROUP INC | $1,859 |
| SPE2DP21F5539From the item's award history | August 12, 2021 | DMS PHARMACEUTICAL GROUP INC | $929 |
| SPE2DP21P0902From the item's award history | August 10, 2021 | DMS PHARMACEUTICAL GROUP INC | $929 |
| SPE2DP21P0899From the item's award history | August 2, 2021 | DMS PHARMACEUTICAL GROUP INC | $4,647 |
| SPE2DP21F5218From the item's award history | July 26, 2021 | DMS PHARMACEUTICAL GROUP INC | $929 |
| SPE2DP21P0607From the item's award history | April 23, 2021 | DMS PHARMACEUTICAL GROUP INC | $929 |
Showing 1 to 10 of 25 results
Source: DLA award notices on SAM.gov for solicitations that included this item (DLA posts them above $25,000), and the contracts of this item's past DLA awards (DLA's award history files and the RFQs' procurement history), joined to FPDS by contract number (an order under a long-term contract by the order and its contract). Amounts are FPDS obligations; DIBBS order totals are not shown. Department of Defense actions appear in FPDS about 90 days after they are signed.